Skip to content

Medical-device intelligence

NJT: Immunohistochemistry Reagents And Kits

FDA product code NJT: Immunohistochemistry Reagents And Kits. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NJT
FDA device name
Immunohistochemistry Reagents And Kits
Device class
1
Regulation number
864.1860
Medical specialty
Hematology
Review panel
PA

FDA definition

according to the regs..."..used after the primary diagnosis of tumor (neoplasm) has been made by conventional histopathology using nonimmunologic histochemical stains, such as hematoxylin and eosin.
Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 92 recall records in the covered releases, across 12 source company names and 1 product codes. Dated history runs from Oct 14, 2005 to Nov 3, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NJT · Immunohistochemistry Reagents And Kits092

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

92 matching records
Device / recordCompany in FDA recordSourceSource date
Bond Ready-To-Use Primary Antibody Thyroid Transcription Factor-1 (SPT24); 7 mL vial; an in vitro diagnostic reagent for the qualitative identifi…Z-2497-2010 · NJTLeica Microsystems, Inc.RecallSep 25, 2010FDA classification date
Lyophilized Mouse Monoclonal Antibody Thyroid Transcription Factor-1; 0.1 mL and 1 mL lyophilized tissue culture supernatant in vials; an in vitr…Z-2498-2010 · NJTLeica Microsystems, Inc.RecallSep 25, 2010FDA classification date
Liquid Mouse Monoclonal Antibody Thyroid Transcription Factor-1; 1 mL liquid tissue culture supernatant in a 1 mL vial; an in vitro diagnostic re…Z-2499-2010 · NJTLeica Microsystems, Inc.RecallSep 25, 2010FDA classification date
NeoMarkers Rabbit Monoclonal anti-Human Cyclin D1 Antibody (Clone SP4), immunochemistry Reagent and Kit, For In Vitro Diagnostic use, manufacture…Z-2424-2010 · NJTLab Vision CorporationRecallSep 15, 2010FDA classification date
Super Sensitive Link-Label IHC Detection System/Mega Volume, RTU Multi-Link-HRP, REF/Cat. No. QP300-XAK, Kit containing reagent vials, Bio-Genex…Z-0217-2007 · NJTBiogenex LaboratoriesRecallDec 8, 2006FDA classification date
Anti-CD45 Cocktail antibody in 6 ml vials; Cat. No. AM371-5M , manufactured and distributed by BioGenex, San Ramon, CAZ-1519-06 · NJTBiogenex LaboratoriesRecallSep 23, 2006FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0310-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0311-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0312--06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0313-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0314-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0315-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0316-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0317-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0318-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0319-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and…Z-0320-06 · NJTDakocytomation California IncRecallDec 23, 2005FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗